NCT00221546View on ClinicalTrials.gov

Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Cystic Fibrosis
Interventions
DRUG

Giving DHA-rich supplement

Giving DHA-rich supplement to patients.

Trial Locations (1)

9000

University Hospital Ghent, Ghent

All Listed Sponsors
collaborator

Belgian Society against Cystic Fibrosis

UNKNOWN

lead

University Hospital, Ghent

OTHER

NCT00221546 - Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter